A novel healthy metabolic phenotype developed among a cohort of families enriched for longevity

Long Life Family Study

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

Background: Long-lived individuals and their offspring have healthier metabolic characteristics than expected, such as more favorable levels of fasting glucose, insulin, and lipids than controls without longevity. Dysregulation in metabolic pathways has also shown to predict accelerated aging. Using information from the Long Life Family Study (LLFS), a multi-center study of two-generation families selected for exceptional longevity, we developed an indicator of healthy metabolism to determine whether metabolic health was more prevalent in a subset of LLFS families and whether it was heritable and associated with other metrics of healthy aging. Methods: A Latent Profile Analysis was applied to age- and gender-adjusted z-scores of fasting levels of glucose, insulin, triglycerides, and high-density lipoprotein cholesterol, body mass index, waist circumference, interleukin-6, and C-reactive protein. Families were defined as meeting the healthy metabolic phenotype if ≥2 and ≥50% of their offspring were classified into a latent subgroup with a profile of healthier metabolic markers than expected given age and gender relative to all LLFS offspring. Results: The log odds of being classified into the latent subgroup with a healthy profile of metabolic markers was heritable (h 2 = 0.40, p < 0.001). Among 388 families, 39 (10%) met the healthy metabolic phenotype. Participants from these families had somewhat better cognition than those from remaining families. Proband-generation participants from families who met the healthy metabolic phenotype also had better pulmonary functioning and physical performance. Conclusions: The better cognition, pulmonary function, and physical performance among probands from families with the healthy metabolic phenotype may indicate that this subset of LLFS families have a more extreme longevity phenotype than other LLFS families since cognitive, physical, and pulmonary function are top mortality predictors for older adults. Future work is needed to determine if rare or protective alleles confer a healthy metabolic phenotype in this subset of LLFS families with exceptional metabolism.

Original languageEnglish
JournalMetabolism: Clinical and Experimental
Volume94
Pages (from-to)28-38
ISSN0026-0495
DOIs
Publication statusPublished - 2019

Fingerprint

Lung
Cognition
Fasting
Insulin
Metabolic Networks and Pathways
HDL Cholesterol
Interleukin-6
Body Mass Index
Alleles
Lipids
Health

Keywords

  • Cognition
  • Healthy aging
  • Longevity
  • Metabolism

Cite this

@article{f8816ff91baf4184bb26dcc58a7d3185,
title = "A novel healthy metabolic phenotype developed among a cohort of families enriched for longevity",
abstract = "Background: Long-lived individuals and their offspring have healthier metabolic characteristics than expected, such as more favorable levels of fasting glucose, insulin, and lipids than controls without longevity. Dysregulation in metabolic pathways has also shown to predict accelerated aging. Using information from the Long Life Family Study (LLFS), a multi-center study of two-generation families selected for exceptional longevity, we developed an indicator of healthy metabolism to determine whether metabolic health was more prevalent in a subset of LLFS families and whether it was heritable and associated with other metrics of healthy aging. Methods: A Latent Profile Analysis was applied to age- and gender-adjusted z-scores of fasting levels of glucose, insulin, triglycerides, and high-density lipoprotein cholesterol, body mass index, waist circumference, interleukin-6, and C-reactive protein. Families were defined as meeting the healthy metabolic phenotype if ≥2 and ≥50{\%} of their offspring were classified into a latent subgroup with a profile of healthier metabolic markers than expected given age and gender relative to all LLFS offspring. Results: The log odds of being classified into the latent subgroup with a healthy profile of metabolic markers was heritable (h 2 = 0.40, p < 0.001). Among 388 families, 39 (10{\%}) met the healthy metabolic phenotype. Participants from these families had somewhat better cognition than those from remaining families. Proband-generation participants from families who met the healthy metabolic phenotype also had better pulmonary functioning and physical performance. Conclusions: The better cognition, pulmonary function, and physical performance among probands from families with the healthy metabolic phenotype may indicate that this subset of LLFS families have a more extreme longevity phenotype than other LLFS families since cognitive, physical, and pulmonary function are top mortality predictors for older adults. Future work is needed to determine if rare or protective alleles confer a healthy metabolic phenotype in this subset of LLFS families with exceptional metabolism.",
keywords = "Cognition, Healthy aging, Longevity, Metabolism",
author = "Marron, {Megan M.} and Iva Miljkovic and Boudreau, {Robert M.} and Kaare Christensen and Feitosa, {Mary F.} and Lee, {Joseph H.} and Paola Sebastiani and Bharat Thyagarajan and Wojczynski, {Mary K.} and Zmuda, {Joseph M.} and Newman, {Anne B.} and {Long Life Family Study}",
year = "2019",
doi = "10.1016/j.metabol.2019.01.010",
language = "English",
volume = "94",
pages = "28--38",
journal = "Metabolism",
issn = "0026-0495",
publisher = "Heinemann",

}

A novel healthy metabolic phenotype developed among a cohort of families enriched for longevity. / Long Life Family Study.

In: Metabolism: Clinical and Experimental, Vol. 94, 2019, p. 28-38.

Research output: Contribution to journalJournal articleResearchpeer-review

TY - JOUR

T1 - A novel healthy metabolic phenotype developed among a cohort of families enriched for longevity

AU - Marron, Megan M.

AU - Miljkovic, Iva

AU - Boudreau, Robert M.

AU - Christensen, Kaare

AU - Feitosa, Mary F.

AU - Lee, Joseph H.

AU - Sebastiani, Paola

AU - Thyagarajan, Bharat

AU - Wojczynski, Mary K.

AU - Zmuda, Joseph M.

AU - Newman, Anne B.

AU - Long Life Family Study

PY - 2019

Y1 - 2019

N2 - Background: Long-lived individuals and their offspring have healthier metabolic characteristics than expected, such as more favorable levels of fasting glucose, insulin, and lipids than controls without longevity. Dysregulation in metabolic pathways has also shown to predict accelerated aging. Using information from the Long Life Family Study (LLFS), a multi-center study of two-generation families selected for exceptional longevity, we developed an indicator of healthy metabolism to determine whether metabolic health was more prevalent in a subset of LLFS families and whether it was heritable and associated with other metrics of healthy aging. Methods: A Latent Profile Analysis was applied to age- and gender-adjusted z-scores of fasting levels of glucose, insulin, triglycerides, and high-density lipoprotein cholesterol, body mass index, waist circumference, interleukin-6, and C-reactive protein. Families were defined as meeting the healthy metabolic phenotype if ≥2 and ≥50% of their offspring were classified into a latent subgroup with a profile of healthier metabolic markers than expected given age and gender relative to all LLFS offspring. Results: The log odds of being classified into the latent subgroup with a healthy profile of metabolic markers was heritable (h 2 = 0.40, p < 0.001). Among 388 families, 39 (10%) met the healthy metabolic phenotype. Participants from these families had somewhat better cognition than those from remaining families. Proband-generation participants from families who met the healthy metabolic phenotype also had better pulmonary functioning and physical performance. Conclusions: The better cognition, pulmonary function, and physical performance among probands from families with the healthy metabolic phenotype may indicate that this subset of LLFS families have a more extreme longevity phenotype than other LLFS families since cognitive, physical, and pulmonary function are top mortality predictors for older adults. Future work is needed to determine if rare or protective alleles confer a healthy metabolic phenotype in this subset of LLFS families with exceptional metabolism.

AB - Background: Long-lived individuals and their offspring have healthier metabolic characteristics than expected, such as more favorable levels of fasting glucose, insulin, and lipids than controls without longevity. Dysregulation in metabolic pathways has also shown to predict accelerated aging. Using information from the Long Life Family Study (LLFS), a multi-center study of two-generation families selected for exceptional longevity, we developed an indicator of healthy metabolism to determine whether metabolic health was more prevalent in a subset of LLFS families and whether it was heritable and associated with other metrics of healthy aging. Methods: A Latent Profile Analysis was applied to age- and gender-adjusted z-scores of fasting levels of glucose, insulin, triglycerides, and high-density lipoprotein cholesterol, body mass index, waist circumference, interleukin-6, and C-reactive protein. Families were defined as meeting the healthy metabolic phenotype if ≥2 and ≥50% of their offspring were classified into a latent subgroup with a profile of healthier metabolic markers than expected given age and gender relative to all LLFS offspring. Results: The log odds of being classified into the latent subgroup with a healthy profile of metabolic markers was heritable (h 2 = 0.40, p < 0.001). Among 388 families, 39 (10%) met the healthy metabolic phenotype. Participants from these families had somewhat better cognition than those from remaining families. Proband-generation participants from families who met the healthy metabolic phenotype also had better pulmonary functioning and physical performance. Conclusions: The better cognition, pulmonary function, and physical performance among probands from families with the healthy metabolic phenotype may indicate that this subset of LLFS families have a more extreme longevity phenotype than other LLFS families since cognitive, physical, and pulmonary function are top mortality predictors for older adults. Future work is needed to determine if rare or protective alleles confer a healthy metabolic phenotype in this subset of LLFS families with exceptional metabolism.

KW - Cognition

KW - Healthy aging

KW - Longevity

KW - Metabolism

U2 - 10.1016/j.metabol.2019.01.010

DO - 10.1016/j.metabol.2019.01.010

M3 - Journal article

VL - 94

SP - 28

EP - 38

JO - Metabolism

JF - Metabolism

SN - 0026-0495

ER -